Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Climb Bio Inc.

    NASDAQ: CLYM · Real-Time Price · USD
    1.40
    0.16 (12.90%)
    At close: Jun 06, 2025, 3:59 PM
    1.41
    1.08%
    After-hours: Jun 06, 2025, 07:53 PM EDT

    Climb Bio Statistics

    Share Statistics

    Climb Bio has 67.58M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 67.58M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,159

    FTD / Avg. Volume

    n/a
    		 0.75%

    Short Selling Information

    The latest short interest is 2.19M, so 3.25% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.19M

    Short % of Shares Out

    n/a
    		 3.25%

    Short % of Float

    n/a
    		 6.08%

    Short Ratio (days to cover)

    n/a
    		 15.3

    Valuation Ratios

    The PE ratio is -1.17 and the forward PE ratio is -1.27. Climb Bio's PEG ratio is 0.1.

    PE Ratio

    n/a
    		 -1.17

    Forward PE

    n/a
    		 -1.27

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.41

    P/FCF Ratio

    n/a
    		 -5.57

    PEG Ratio

    n/a
    		 0.1
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Climb Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 31.41, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 31.41

    Quick Ratio

    n/a
    		 31.41

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-4,346,882.35

    Employee Count

    n/a
    		 17

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is -0.16, so Climb Bio's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.16

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 1.24

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 61.5

    Average Volume (20 Days)

    n/a
    		 154,126

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -82.02M

    Net Income

    n/a
    		 -73.9M

    EBITDA

    n/a
    		 -30.36M

    EBIT

    n/a
    		 -30.36M

    Earnings Per Share (EPS)

    n/a
    		 -1.14
    Full Income Statement

    Balance Sheet

    The company has 87.23M in cash and 532K in debt, giving a net cash position of 86.7M.

    Cash & Cash Equivalents

    n/a
    		 87.23M

    Total Debt

    n/a
    		 532K

    Net Cash

    n/a
    		 86.7M

    Retained Earnings

    n/a
    		 -229.88M

    Total Assets

    n/a
    		 217.19M

    Working Capital

    n/a
    		 149.94M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -15.56M and capital expenditures 0, giving a free cash flow of -15.56M.

    Operating Cash Flow

    n/a
    		 -15.56M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -15.56M

    FCF Per Share

    n/a
    		 -0.32
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CLYM does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CLYM is $10, which is 614.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 614.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 7.65

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist